Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

10,627 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,473
Recruiting: 1,285
Ph III recruiting: 130
Growth YoY: +6.4%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,641)

clinicaltrialsPublishedShowing 101–150 of 1,370 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07760454	A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple Myeloma	recruiting	Phase 1 / Phase 2	68	UCARsgen Biotech LimitedOTHER	1	Sep 17, 2026	clinicaltrials
NCT07825064	Cevostamab in Combination With Pomalidomide and Dexamethasone After BCMA- Targeting CAR T-Cell Therapy in Participants With Previously Treated Multiple Myeloma	recruiting	Phase 2	45	Hoffmann-La RocheINDUSTRY	1	Sep 17, 2026	clinicaltrials